Treatment of patients with essential tremor

G Deuschl, J Raethjen, H Hellriegel, R Elble - The Lancet Neurology, 2011 - thelancet.com
Essential tremor is a common movement disorder. Tremor severity and handicap vary
widely, but most patients with essential tremor do not receive a diagnosis and hence are …

Essential tremor: diagnosis and management

V Shanker - bmj, 2019 - bmj.com
Essential tremor is one of the most common movement disorders in adults and can affect
both children and adults. An updated consensus statement in 2018 redefined essential …

Botulinum toxin in clinical practice

J Jankovic - Journal of Neurology, Neurosurgery & Psychiatry, 2004 - jnnp.bmj.com
Botulinum toxin, the most potent biological toxin, has become a powerful therapeutic tool for
a growing number of clinical applications. This review draws attention to new findings about …

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review)[RETIRED] Report of the Therapeutics and Technology …

DM Simpson, A Blitzer, A Brashear, C Comella… - Neurology, 2008 - AAN Enterprises
Objective: To perform an evidence-based review of the safety and efficacy of botulinum
neurotoxin (BoNT) in the treatment of movement disorders. Methods: A literature search was …

Practice Parameter: Therapies for essential tremor [RETIRED] Report of the Quality Standards Subcommittee of the American Academy of Neurology

TA Zesiewicz, R Elble, ED Louis, RA Hauser… - Neurology, 2005 - AAN Enterprises
Background: Essential tremor (ET) is one of the most common tremor disorders in adults and
is characterized by kinetic and postural tremor. To develop this practice parameter, the …

Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders

M Hallett, A Albanese, D Dressler, KR Segal… - Toxicon, 2013 - Elsevier
Botulinum neurotoxin (BoNT) can be injected to achieve therapeutic benefit across a large
range of clinical conditions. To assess the efficacy and safety of BoNT injections for the …

Treatment of hyperkinetic movement disorders

J Jankovic - The Lancet Neurology, 2009 - thelancet.com
Parkinson's disease, the most common hypokinetic movement disorder, has received much
attention from the clinical and scientific community, but there has been a relative paucity of …

An evidence-based review of botulinum toxin (Botox) applications in non-cosmetic head and neck conditions

R Persaud, G Garas, S Silva… - JRSM short …, 2013 - journals.sagepub.com
Botulinum toxin (Botox) is an exotoxin produced from Clostridium botulinum. It works by
blocking the release of acetylcholine from the cholinergic nerve end plates leading to …

Botulinum toxin: basic science and clinical uses in otolaryngology

A Blitzer, L Sulica - The Laryngoscope, 2001 - Wiley Online Library
The role of botulinum toxin as a therapeutic agent is expanding rapidly in otolaryngology.
Botulinum toxin is a protease that blocks the release of acetylcholine from nerve terminals …

Recommendations of the Neurolaryngology Study Group on laryngeal electromyography

A Blitzer, RL Crumley, SH Dailey… - … —Head and Neck …, 2009 - journals.sagepub.com
The Neurolaryngology Study Group convened a multidisciplinary panel of experts in
neuromuscular physiology, electromyography, physical medicine and rehabilitation …